![Jordi Mata-Fink](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jordi Mata-Fink
Chief Executive Officer at Gate Bioscience, Inc.
Jordi Mata-Fink active positions
Companies | Position | Start | End |
---|---|---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2012-12-31 | - |
Gate Bioscience, Inc.
![]() Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Chief Executive Officer | 2020-12-31 | - |
Founder | 2020-12-31 | - |
Career history of Jordi Mata-Fink
Former positions of Jordi Mata-Fink
Companies | Position | Start | End |
---|---|---|---|
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Founder | 2016-12-31 | - |
RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
Founder | 2013-12-31 | - |
Training of Jordi Mata-Fink
Stanford University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Founder | 3 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
![]() Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
![]() Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
- Stock Market
- Insiders
- Jordi Mata-Fink
- Experience